Compare Charles River Laboratories Intl. Inc (CRL) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Rigetti Computing Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $229.34 (market cap $11.14B), while Rigetti Computing Inc trades at $15.35 (market cap $5.35B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.1× Rigetti Computing Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals.
| CRL | RGTI | |
|---|---|---|
Market Cap | $11.14B | $5.35B |
Sector | Health | Technology |
52-Week High | $233.60 | $56.34 |
52-Week Low | $145.57 | $12.72 |
Enterprise Value | $14.00B | $4.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
Rigetti Computing (RGTI) trades at $15.36, down 7.13% in the last 24 hours, with a bearish technical signal but bullish oscillators. The company reported a net loss of $216.21 million in 2025, with a negative net income margin of -2,253.59%, while revenue grew to $7.09 million. Recent news highlights quantum computing interest following Quantinuum's IPO and Rigetti's infrastructure developments, including the Fab-1 facility and a 108-qubit contract.
Despite significant losses and cash burn, analyst consensus is strongly bullish with an 85.71% buy rating and a $32.67 price target, suggesting over 112% upside. Key risks include high cash burn rates, intense competition, and the long timeline to quantum advantage, requiring careful risk assessment for speculative investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
